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We report here the on-command cargo controlled delivery 
using an alternating magnetic field (AMF) from magnetic 
silica mesoporous supports capped with a lipid bilayer.  
In recent years scientists have developed different kinds of drug 10 
delivery systems. In this field, the design of chemical and 
physical stimuli-responsive gated mesoporous materials have 
recently demonstrated to be an excellent approach for the 
development of smart nanodevices. In fact, the unique 
characteristics of functionalized mesoporous silica supports such 15 
as high homogeneous porosity, inertness, robustness, thermal 
stability, the presence of tunable pore sizes, homogeneous pore 
distribution and high loading capacity, makes these scaffoldings 
ideal for hosting functional guest molecules. Additionally, the 
possibility of incorporating in the external surface functional 20 
groups able to open or close at will or including capping 
molecules, provides advanced control release applications. One 
of the most captivating features of such systems is the possibility 
to prepare “zero release” devices that deliver entrapped guests 
exclusively upon the application of an external stimulus.1 25 
Chemical stimuli2 as redox molecules, selected anions, pH 
changes and biomolecules have been used to develop gated 
materials with controlled release features. In contrast to chemical, 
physical stimuli have the advantage of displaying cargo release 
which can, in principle, be controlled spatially and temporally by 30 
fine-tuning the area and time where and when the stimuli is 
applied. Among different physical triggers, such as light3 and 
temperature,4 the use of magnetic fields is captivating. Although 
some examples have been reported for magnetically guided 
delivery, the use of magnetic fields to control the opening of 35 
gated mesoporous materials is a barely studied area. As far as we 
know only two examples have been reported. In the first one, 
Stoddart, Zink et al. used a material that combined zinc-doped 
iron oxide nanocrystals within mesoporous silica nanoparticles 
that were capped with pseudorotaxanes.4b Upon application of an 40 
alternating magnetic field (AMF), the nanocrystals generated 
local internal heating, causing the dethread of the 
pseudorotaxanes and cargo release. The second example was 
described by Vallet et al.4c In their work, the authors 
demonstrated that DNA/magnetic NP conjugates were able to cap 45 
the pores of silica particles upon hybridization of DNA strands. 
The application of an AMF resulted in pore uncapping due to 
DNA melting and the subsequent release of fluorescein. 
 Taking into account these concepts and being aware of the 
promising features of silica mesoporous supports as containers 50 
and magnetic fields as triggers we focused our attention on the 
development of new tailor-made simple to prepare magnetic-
responsive gated mesoporous materials. The expected 
performance of the designed capped support, depicted in Scheme 
1, is based on the use mesoporous silica NPs (of ca. 100 nm) 55 
loaded with a suitable reporter (i.e. the dye methylene blue) and 
containing superparamagnetic iron oxide nanocrystals (SPION). 
The NPs are then capped with a lipid bilayer. The presence of an 
AMF was expected to increase the lipid bilayer permeability 
which might result in cargo release. 60 
Scheme 1. Solid S2 expected performance. 
 In order to prepare the gated nanodevice, in a first step, SPION 
were synthesized following the procedure reported by Bruce et 
al..5 Typical transmission electron microscopy (TEM) images of 
the prepared solid showed well defined NPs, whereas powder X-65 
ray diffraction (XRD) studies displayed the characteristic peaks 
of SPION. The average diameter of the synthesized SPION was 
estimated to be of ca. 18.6 nm, using Scherrer’s formula.6 
Additionally, by vibrating sample magnetometer (VSM) analysis, 
a magnetization saturation value of 52.8 emu g-1 was calculated 70 
for the prepared SPION (see Figure SI-6a for details).  
  In a second step, the magnetic mesoporous NPs (S1) were 
synthesized by hydrolysis of a silica precursor (TEOS) in a basic 
ferrofluid-CTAB solution. XRD patterns of S1 (Figure 1a) 
showed the four low angle reflections distinctive of a mesoporous 75 
MCM-41-type material and characteristic reflections of SPION in 
the 28<2θ<68 range. Moreover, representative scanning 
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in Figure 1b showed the typical matrix of a mesoporous phase 
surrounding the superparamagnetic NPs.  
Figure 1. (a) Powder X-ray diffraction pattern of solid S1 from 2θ=2° to 
8° showing the typical four low-angle reflections of the MCM-41 
hexagonal array and, from 2θ=28° to 68° showing the reflections that can 5 
be indexed to the SPIONs cubic array. b) STEM image of S1 showing the 
typical porosity of the MCM-41 mesoporous matrix and the 
superparamagnetic particles. 
 From EDX analysis, the molar ratio between silicon and iron 
in S1 was calculated to be 4.0±0.5, this value being close to the 10 
theoretically expected Si/Fe molar ratio of 5.0 employed in the 
reaction mixture used in the synthesis of the NPs. From VSM 
studies, a magnetization saturation of 14.0 emu g-1 was calculated 
for S1 (Figure 2). This lower magnetization value when 
compared with SPION is coherent with the calculated silicon/iron 15 
ratio in the composite material S1. Moreover, despite this 
reduction in the magnetization behaviour, solid S1 still display 








Figure 2. Magnetization curves of solid S1. The inset shows the 
expansion of the area marked by the dashed rectangle.  
 For the preparation of the gated material S2, solid S1 was 
dispersed in a solution of methylene blue in water and stirred for 
24 hours. Moreover, unilamellar lipid vesicles of  1,2-dioleoyl-30 
sn-glycero-3-phosphocholine (DOPC) were obtained  by 
evaporating a solution of the lipid in chloroform in a precleaned 
glass vial and further redispersion in phosphate buffer saline 
(PBS) 0.25x (pH=7.4, phosphate concentration 2.5x10-3 mol L-
1).7 Then, 100 μL of the vesicle mixture was vigorously mixed 35 
with 25 μL of a suspension of the loaded solid S1 (50 mg) in 5 
mL of a saturated solution of methylene blue. The final solid S2 
was obtained after several steps of centrifugation and washing 
with PBS 0.25x. Such final S2 mesoporous NP-supported lipid 
bilayers are somehow similar to some recently reported systems8 40 
which synergistically combine properties of liposomes and 
nanoporous particles. 
 The controlled release performance of S2 was evaluated via 
methylene blue delivery experiments in water in both, the 
presence and the absence of an AMF. In a typical experiment, 45 
two different samples were prepared by dispersing S2 in water in 
the presence of PBS (pH=7.4). One batch was exposed to an 
AMF (50 Hz, 1570 G) while the other was taken as control. To 
eliminate possible macroscopic thermal effects from the magnet, 
samples exposed to an AMF were immersed in a water bath at 50 
21±1 °C (Figure SI-2). After a fixed time, the corresponding 
suspensions were centrifuged and the released cargo was 
determined through the monitorization of the UV-vis absorbance 











Figure 3. Cumulative release profile of methylene blue from solid S2 65 
dispersed in PBS a) without AMF and b) in the presence of an AMF 
(50Hz, 1570 G). Release data were normalized to the maximum delivery 
obtained for solid S2 in the presence of the AMF. 
 The results (Figure 3) confirmed the fine tune triggering event; 
i.e. whereas solid S2 displayed no release, the application of an 70 
AMF induced the release of the entrapped guest. A detailed study 
of the data indicated that more than 90% of the maximum 
deliverable methylene blue dye was released within the first 4 
hours in samples exposed to AMF, whereas it was necessary to 
wait for several weeks in order to observe a significant delivery 75 
of the dye from S2 in water in the absence of the magnetic field. 
Furthermore, to study the influence of temperature on the lipid 
bilayer permeability we carried out release experiments at 25 and 
50 ºC in the absence of an AMF (see Figure SI-7). We found a 
massive delivery at 50 ºC even at short times, while the release at 80 
25 ºC was negligible. Thus, the observed sustained delivery from 
S2 observed in the presence of an AMF is assigned to a 
combination of the lipid bilayer local warming and changes in its 
permeability promoted by the vibration of the NPs in the presence 
of an AMF.9 Moreover, in order to additionally assess this 85 
magnetic triggering effect some further control experiments were 
carried out. A mesoporous material loaded with the methylene 
blue dye, capped with the lipid bilayer but lacking the presence of 
SPION (solid S3) was prepared. Suspensions of S3 in water 
displayed no release of the cargo either in the absence or in the 90 
presence of an AMF.  This behaviour draws attention to the 
crucial role played by SPION in the gating mechanism. 
 Cell internalization of mesoporous silica NPs bearing gated 
stimuli-responsive scaffoldings is an appealing new 
interdisciplinary research field on the frontier of nanoscience. 95 
One fundamental goal in this area is the understanding of the 
toxicity of these NPs at cellular level as a crucial factor for the 
rational design of nanomaterials for biomedical applications. 
Even being aware of the non-toxic nature of lipid bilayers,10 we 
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tested capped S2 NPs at different concentrations for prospective 
cell viability assays using the MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) and XTT (sodium(2,3-bis(2-
methoxy-4-nitro-5-sulphophenyl)-2H-tetrazolium-5-
carboxanilide) method11 in various human cell lines including 5 
human nervous (A172), liver (HEPG2), heart (HCM), lung 
(A549), kidney (293T), colon (SW480), brain (BE(2)-C) and skin 
(A431). According to the results depicted in Figure 4 and SI-8 to 
SI-11, cell viabilities in the presence of S2 were both cell-type- 
and NP-concentration-dependent.  10 
Figure 4. Cell viabilities resulted from MTT assay after 4 hours of 
treatment with different concentrations of solid S2. 
 As remarkable outcome, cellular toxicity of S2 at 
concentrations lower than 0.5 mg mL-1 was negligible for all the 
cell lines under study, whereas at higher concentrations (from 1 15 
to 4 mg mL-1) a trace of toxicity was observed for brain, nervous, 
lung, and heart human cell lines in agreement with the usually 
more sensitive behaviour of these cells to alien materials. 
 This preliminary study was completed treating human 
erythromyeloblastoid leukemia suspension cells12 with S2 to 20 
obtain information about the effect of the NPs in the cell cycle. 
Solid S2 did not show detectable effects on the cell-life cycle of 
these cells, even at high applied dosage (i.e. 4 mg mL-1) (see 
Figure SI-12 (a-f)). In particular, there were no traces of 
variations in apoptotic fraction (sub G0G1 stage), the G0G1 phase, 25 
S phase (i.e. DNA synthesis stage), and G2M phase areas before 
and after interaction with NPs. 
 In summary, we have reported here a new magnetically-
triggered gated material in which cargo delivery can be remotely 
activated by increasing lipid bilayer permeability thanks to the 30 
interaction of SPION in a silica mesoporous support with an 
AMF. The easy preparation of the gated material, the robustness 
and high loading capacity of the cargo reservoir, the wide range 
of possibilities that lipid bilayers have in relation to their 
straightforward non-covalent modification with a variety of 35 
ligands, the biocompatibility displayed by the NPs in human cell 
lines, combined with the smart remote release activation using a 
friendly simple AMF make these new hybrid nanomaterials 
attractive systems for the future design of on command delivery 
nanodevices in a wide range of applications. 40 
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Concentration S2 (mg mL-1)
A172 (Nervous) A549 (Lung) BE(2)-C (Brain)
HEPG2 (Liver) 293T (Kidney) A-431 (Skin)
HCM (Heart) SW480 (Colon)
